¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"relative refractory phase"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
in-phase image
À§»ó³»¿µ»ó
inspiratory phase
µé¼û»ó, Èí±â»ó
inspiratory phase time
µé¼û½Ã°£, Èí±â½Ã°£
internal phase
ºÐ»ê±â
latent phase
1. ÀáÀç±â 2. Àẹ±â
leptotene phase
°¡´Â¼¶À¯±â, ¼¼»ç±â
logarithmic phase
´ë¼öÁõ½Ä±â
lactiferous phase
¼öÀ¯±â
luteal phase
Ȳ(»ö)ü±â
luteal phase defect
Ȳ(»ö)ü±â°á¼Õ
luteal phase endometrial biopsy
Ȳ(»ö)ü±âÀڱ󻸷»ý°Ë
lysogenic phase
¿ë¿ø±â
mitosis phase
À¯»çºÐ¿±â
modulation phase
º¯Á¶À§»ó
manic phase
Á¶Áõ±â, µé¶ä±â
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
diastolic phase
È®Àå±â, À̿ϱâ
diplotene phase
°ã¼¶À¯±â
diurnal phase
ÁÖ°£»ó
phase delay
À§»óÁö¿¬
phase difference
À§»óÂ÷
phase display
À§»óÇ¥½Ã
phase encode direction
À§»óºÎȣȹæÇâ
ejection phase
¹ÚÃâ±â
equilibrium phase
ÆòÇü±â
erythrocytic phase
ÀûÇ÷±¸³»¹ßÀ°±â
expiratory phase
È£±â»ó
expiratory phase time
³¯¼û½Ã°£, È£±â½Ã°£
exponential phase
(¢¡logarithmic phase) ´ë¼öÁõ½Ä±â
phase encoding
À§»óºÎÈ£È
phase shift effect
À§»óº¯À§È¿°ú
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
relative valvular insufficiency
»ó´ëÀû ÆÇÆó¼âºÎÀü(Áõ)(ßÓÓßîÜ÷ûøÍáðÝÕîïñø)
relative viscosity
»ó´ëÁ¡µµ(ßÓÓßïÄöô).
3D phase contrast angiography
3Â÷¿ø À§»ó ´ëÁ¶ Ç÷°üÁ¶¿µ¼ú
DNA synthetic phase
DNA ÇÕ¼º±â
Go phase
Go±â
accelerated death phase
°¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
acceleration phase
ÃËÁø±â, °¡¼Ó±â(Ê¥áÜÑ¢).
acute phase protein
±Þ¼ºº´±â´Ü¹éÁú
acute phase reactant
±Þ¼º±â ÀÛ¿ë¹°Áú
acute phase reaction
±Þ¼º±â¹ÝÀÀ(¡Ñ¢Úãëë)
acute phase reactive protein
±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
acute phase serum
±Þ¼ºº´±âÇ÷û
acute phase substances
±Þ¼º±â ¹°Áú(ÐáàõÑ¢Úªòõ).
advanced sleep phase syndrome
ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
anal-sadistic phase
Ç×¹®-°¡ÇÐ(½Ã)±â
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
relative leukocytosis
ºñ±³¹éÇ÷±¸Áõ°¡Áõ(ÝïÎòÛÜúìϹñòÊ¥ñø).
relative leukocytosis
ºñ±³¹éÇ÷±¸Áõ°¡Áõ(ÝïÎòÛÜúìϹñòÊ¥ñø)
relative magnetic permeability
relative measurement
ºñ±³ÃøÁ¤(ËÓË´Ì¬Ëø).
relative metabolic rate
»ó´ëÀû ´ë»çÀ².
relative motion
»ó´ë¿îµ¿(ßÓÓßê¡ÔÑ).
relative osteoid volume
»ó´ëÀû À¯°ñ·®
relative polycythemia
»ó´ëÀû ÀûÇ÷±¸Áõ°¡Áõ(ßÓÓßîÜîåúìϹñòÊ¥ñø).
relative polycythemia
»ó´ëÀû ÀûÇ÷±¸Áõ°¡Áõ(ßÓÓßîÜîåúìϹñòÊ¥ñø)
relative risk
ºñ±³À§Çèµµ
relative risk
ºñ±³À§Çèµµ(ËÓË´Ëô̴̬).
relative risk estimation
»ó´ë(-Àû) À§Çèµµ ÃßÁ¤(õÏïÒ)
relative scotoma
»ó´ë¾ÏÁ¡(ßÓÓßäÞïÇ).
relative sterility
»ó´ëÀû »ý½ÄºÒ´É(Áõ)(ßÓÓßîÜßæãÖÝÕÒö(ñø)).
relative survival rate
»ó´ë»ýÁ¸À²
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½